CClinicalTrials.gg
CompletedNCT04635917Updated Jul 15, 2025

Effects of a Personalized Diet on Cardiometabolic, Microbiome and Metabolomics Profiles in Minority Young Adults

An interventional study of Personalized diet and Conventional dietary advice in Diet Intervention, sponsored by University of Missouri-Columbia. Completed at 1 site in United States. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-15.

Sponsored by University of Missouri-Columbia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
112
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

The proposed study has two primary objectives i.e. to examine how improvements in diet quality via a personalized dietary intervention 1) benefit cardiometabolic outcomes in young Black adults differentially compared to non-Hispanic White adults, and 2) improve carbohydrate and lipid metabolism in relation to the gut microbiome.

Read the detailed description

The study is an 8-wk randomized, controlled, parallel arm clinical trial in which participants (age: 18-35 years, BMI: 25-45 kg/m2, race/ethnicity: Black or White) will be block randomized to a personalized dietary intervention or to receive conventional dietary advice. Outcomes assessed will include metabolites involved in carbohydrate and lipid regulation, gut microbiome composition, and cardiometabolic biomarkers.

02

Conditions studied

  • Diet Intervention

Keywords

  • Personalized
03

In context

Lead sponsor

University of Missouri-Columbia is the lead sponsor of 357 studies on the registry; 70 are open to participants now.

Of its 42 completed or terminated interventional studies of FDA-regulated products, 28 (67%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age: 18-35 years of age
  • BMI: 25-45 kg/m2
  • Black including those of Hispanic ethnicity, and Non-Hispanic White individuals
  • Willingness to consume nuts, fruits and vegetables
  • Willing to comply with study protocol
  • Consistent diet and activity patterns for 4 weeks
  • Weight stable (≤5 kg change over the last 3 months) (Self-reported)
  • Non-smoker >1 year or more

Exclusion criteria

Exclusion Criteria:

  • Allergies to fruits, vegetables, and nuts provided in the study
  • Illicit drug use
  • Recent start of medications that affect metabolism or appetite
  • Antibiotics
  • Coronary artery disease, peripheral artery disease, congestive heart failure, or dyslipidemia requiring drug therapy
  • Uncontrolled hypertension and blood pressure ≥ 180/110 Diabetes
  • Gastrointestinal disease and/or bariatric surgery
  • HIV positivity
  • Pregnant or lactating individuals
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
112 participants (actual)

Study arms

  • Experimental
    Personalized diet - Black adults

    Young Black adults in this group will receive tailored nutrition counseling from a dietitian. To facilitate meeting their dietary goals, participants will be provided with nuts, fruits, and vegetables.

    Other: Personalized diet

  • Experimental
    Personalized diet - White adults

    Young White adults in this group will receive tailored nutrition counseling from a dietitian. To facilitate meeting their dietary goals, participants will be provided with nuts, fruits, and vegetables.

    Other: Personalized diet

  • Other
    Conventional dietary advice- Black adults

    Young Black adults will receive non-personalized, conventional dietary advice based on the MyPlate guidelines.

    Other: Conventional dietary advice

  • Other
    Conventional dietary advice- White adults

    Young White adults will receive non-personalized, conventional dietary advice based on the MyPlate guidelines.

    Other: Conventional dietary advice

Interventions

  • OtherPersonalized diet

    Participants in this group will receive tailored nutrition counseling from a dietitian. To facilitate meeting these dietary goals, participants will be provided with nuts, fruits, and vegetables.

    Also known as: PD

  • OtherConventional dietary advice

    Participants in the CD group will receive non-personalized, conventional dietary advice by a dietitian based on the MyPlate guidelines.

    Also known as: CD

06

What researchers measure

Primary outcomes

  1. Change in diet quality

    Healthy eating index score

    Time frame: Change over 8 weeks

  2. Change in relative intensities of metabolites in blood

    Measured by untargeted metabolomics mass spectrometry

    Time frame: Change over 8 weeks

  3. Change in stool microbiome profiles

    16s rRNA sequencing

    Time frame: Change over 8 weeks

  4. Change in endothelial function

    Reactive hyperemia index

    Time frame: Change over 8 weeks

  5. Matsuda index

    Assessed via a 2-hour oral glucose tolerance test

    Time frame: Change over 8 weeks

  6. Change in lipid profile

    LDL, HDL, triglycerides, total cholesterol

    Time frame: Change over 8 weeks

  7. Change in glucoregulation

    Fasting glucose concentrations

    Time frame: Change over 8 weeks

  8. Change in insulinemic biomarker concentrations

    Fasting insulin and C-peptide concentrations

    Time frame: Change over 8 weeks

  9. Change in blood pressure

    Diastolic and systolic blood pressure

    Time frame: Change over 8 weeks

  10. Change in inflammatory markers

    MCP-1,IL6, IL10, TNFa, hs-CRP, and fibrinogen

    Time frame: Change over 8 weeks

Secondary outcomes

  1. Body Mass

    Body mass will be measured in kg

    Time frame: Every 2 weeks over the 8 week intervention

  2. Body Composition

    Fat mass, fat-free mass

    Time frame: Every 2 weeks over the 8 week intervention

  3. Anthropometrics

    Waist circumference, hip circumference

    Time frame: Every 2 weeks over the 8 week intervention

  4. 24-hour appetite ratings

    Subjective ratings using visual analog scales

    Time frame: Every 4 weeks over the 8 week intervention

  5. Physical activity

    Activity assessment using Actigraphs

    Time frame: Every 4 weeks over the 8 week intervention

  6. Palatability rating of foods

    Hedonic general labelled magnitude scale (gLMS)

    Time frame: Every 2 weeks over the 8 week intervention

  7. Acceptance rating of foods

    9-point food action rating scale

    Time frame: Every 2 weeks over the 8 week intervention

Other outcomes

  1. Transcriptomics profiles

    Untargeted transcriptomics

    Time frame: Baseline and at the end of the 8-week intervention

  2. Attention score

    d2 test of attention

    Time frame: Change over 8 weeks

  3. Memory

    Word recall scores

    Time frame: Change over 8 weeks

  4. Food environment perceptions

    Subjective and objective questionnaires

    Time frame: Baseline and at the end of the 8-week intervention

07

Study locations

1 site
  • University of Missouri-Columbia
    Columbia, Missouri 65211, United States
08

References and documents

Study documents

  • Informed consent form · May 8, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — Individual participant data that underlie the results reported here after deidentification (ie; text, tables, figures, and appendices)

Supporting information: Study protocol

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04635917
Lead sponsor
University of Missouri-Columbia
Collaborators
National Institute on Minority Health and Health Disparities (NIMHD)
Responsible party
Jaapna Dhillon (Assistant Professor, Nutrition & Exercise Phys-MED, University of Missouri-Columbia) — Principal investigator
First posted
Nov 19, 2020
Start date
Dec 22, 2020
Primary completion
Dec 21, 2024
Completion
Dec 21, 2024
Last update
Jul 15, 2025

Study contacts

Jaapna Dhillon, PhD
principal investigator · University of Missouri-Columbia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion